Company Short-Term Debts: XBiotech Inc. (XBIT)

Graphic logo of XBiotech USA (XBIT)

XBiotech Inc. is optimizing expenses through the automated production of proprietary antibodies. However, geopolitics complicate the external registration of drugs, while strict FDA oversight limits access to the niche. On GURU.Markets, the short-term debt chart visualizes current liquidity, where the latest value is recorded as 0.00, allowing traders to accurately assess the dynamics of the company's debt repayment.

Company Short-Term Loans and Borrowings: xbiotech.com (XBIT) for 07/04/2022 - 10/29/2026

XBIT (XBiotech Inc): analytical breakdowns and indicator data

- price and consensus price forecast:
Stock Price XBiotech USA|XBIT - Consensus Target
- market capitalization data:
Market Capitalization XBiotech Inc.|XBIT - Total Enterprise Value
- book capitalization data:
Net Assets per Single Share XBiotech|XBIT - Accounting Value of Company|Market Cap to Net Assets Ratio xbiotech.com|XBIT - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital XBiotech Inc.|XBIT - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio XBiotech USA|XBIT - Company Aggregate Debts|Debt to Book Capitalization Ratio XBiotech Inc.|XBIT - Company Long-Term Loans and Borrowings|Company Short-Term Debts XBiotech
Fundamental company valuation:XBIT xbiotech.com
Flagship merchandise of XBiotech Inc.

XBiotech Inc. relies on autonomous antibody development, where the preservation of intellectual property requires strict liquidity control. By analyzing the size of short-term liabilities, an investor assesses obligations maturing within one year to determine the balance between financial stability and management's ability to fund scientific research without a critical debt load, which shapes the long-term consensus on the business's solvency.

Competitors of XBiotech Inc. (XBIT)

ONC: Company Short-Term Debts|HALO - Company Current Liabilities|Company Short-Term Debts RVMD|AAPG (Ascentage Pharma Corp) - Short-Term Debt|CGON - Company Short-Term Debt|Company Short-Term Loans and Borrowings urogen.com (URGN)|Bicara Therapeutics (BCAX) - Company Current Liabilities|Company Short-Term Loans and Borrowings Personalis Inc (PSNL)|Erasca Corp - Company Short-Term Debts|DCTH - Company Current Liabilities|Y-mAbs Therapeutics - Company Current Liabilities|AURA: Company Short-Term Debts|Company Short-Term Debt candeltx.com CADL|Accuray Inc (ARAY) - Company Short-Term Loans and Borrowings|Company Short-Term Debts SLS (SELLAS Life Sciences Group, Inc.)|Short-Term Debt Actuate Therapeutics Inc (ACTU)|Company Current Liabilities Citius Oncology, Inc. CTOR|Company Short-Term Indebtedness tuhurabio.com (HURA)|Company Short-Term Debts Protara Therapeutics, Inc. TARA|Company Short-Term Debt Fate Therapeutics Inc FATE|Company Short-Term Debts WHWK (Aadi Bio)|TCRX: Short-Term Debt Volume|Company Short-Term Debt CSBR|Short-Term Debt CEL-SCI|OS Therapies (OSTX) - Company Current Liabilities|Amount of Current Liabilities Radiopharm Theranostics Ltd|Artiva Biotherapeutics, Inc. - Company Short-Term Debts|Short-Term Debt adlainortye.com (ANL)|Veru Inc. - Company Short-Term Debts|Company Current Liabilities tempesttx.com TPST|Company Short-Term Debts Xilio (XLO)|Renovaro Inc. (RENB) - Company Short-Term Loans and Borrowings|Company Current Liabilities muraloncology.com MURA|Kairos Pharma (KAPA) - Company Short-Term Loans and Borrowings|OKUR: Company Short-Term Debts|Short-Term Debt Volume GDTC|Company Short-Term Debt Curis, Inc. CRIS|Company Short-Term Indebtedness apollomicsinc.com (APLM)|Tharimmune Corp - Company Short-Term Debts|ADVB - Company Current Liabilities|Company Current Liabilities GNPX (Genprex, Inc.)|Calidi Biotherapeutics (CLDI) - Short-Term Debt Volume|Company Current Liabilities Sunshine Biopharma|Xenetic Biosciences, Inc. (XBIO) - Company Short-Term Indebtedness|Company Short-Term Debts Salarius|Company Short-Term Debt Kitov Pharma|AONC (American Oncology Network) - Company Short-Term Debts|Short-Term Debt Volume beigene.com BGNE|Company Current Liabilities Checkpoint Therapeutics, Inc. (CKPT)|Amount of Current Liabilities Elevation Oncology Inc. ELEV|ICAD: Company Short-Term Debts|IKNA - Company Current Liabilities|NTBL: Company Short-Term Debts|VIRX (Viracta Therapeutics, Inc.) - Company Short-Term Debts|Company Short-Term Debt MorphoSys (MOR)|Company Short-Term Indebtedness NAYA Biosciences Inc|Company Short-Term Debts AAPGV (Ascentage Pharma Group Ltd)